Nanohale AG (ETR:FYB) | WebDisclosure

Basculer en Français

10108	Companies
207161	Keywords
137291	Articles
109798	Press releases

Home
Companies
Nanohale AG

BRIEF

published on 10/01/2024 at 17:11, 1 year 5 months ago

Le biosimilaire FYB202 de Formycon AG approuvé pour les marchés de l'UE et des États-Unis

Formycon AG Approbation De La FDA Entrée Sur Le Marché Biosimilaire Analyse D'investissement
PRESS RELEASE

published on 10/01/2024 at 17:06, 1 year 5 months ago

Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH releases an update on Formycon AG, with analyst Simon Scholes reiterating a BUY rating and raising the price target from EUR 80 to EUR 82. The approval of the biosimilar FYB202 in the EU and US contributes to the positive outlook on Formycon's market share prospects

Investment Recommendation Formycon AG First Berlin Equity Research GmbH FYB202 Approval Biosimilar Market
BRIEF

published on 09/30/2024 at 07:35, 1 year 5 months ago

Formycon and Fresenius Kabi Receive FDA Approval for Biosimilar Otulfi

FDA Approval Biosimilar Formycon Fresenius Kabi Otulfi
BRIEF

published on 09/30/2024 at 07:35, 1 year 5 months ago

Formycon et Fresenius Kabi reçoivent l'approbation de la FDA pour le biosimilaire Otulfi

Approbation De La FDA Formycon Fresenius Kabi Biosimilaire Otulfi
PRESS RELEASE

published on 09/30/2024 at 07:30, 1 year 5 months ago

Formycon and Fresenius Kabi receive FDA approval for FYB202/ OtulfiTM (ustekinumab-aauz)
Formycon and Fresenius Kabi receive FDA approval for FYB202/OtulfiTM (ustekinumab-aauz) to treat several conditions including Crohn’s disease and psoriasis, expanding biosimilar market presence

FDA Approval Biosimilar Formycon Fresenius Kabi Ustekinumab
BRIEF

published on 09/27/2024 at 22:01, 1 year 6 months ago

FDA Grants Approval for Stelara® Biosimilar FYB202/OtulfiTM

FDA Approval Pharmaceutical Formycon AG Biosimilar Stelara®
BRIEF

published on 09/27/2024 at 22:01, 1 year 6 months ago

La FDA approuve le biosimilaire Stelara® FYB202/OtulfiTM

Formycon AG Approbation De La FDA Pharmaceutique Biosimilaire Stelara®
PRESS RELEASE

published on 09/27/2024 at 21:56, 1 year 6 months ago

EQS-Adhoc: FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz)
FDA grants approval for Stelara Biosimilar FYB202/Otulfi (ustekinumab-aauz) by Formycon AG. Approval based on comprehensive data evaluation. Contact: Sabrina Mueller, Formycon AG

FDA Approval Formycon AG FYB202 Stelara Biosimilar Sabrina Mueller
BRIEF

published on 09/27/2024 at 09:05, 1 year 6 months ago

European Commission Approves Formycon and Fresenius Kabi's Biosimilar FYB202/Otulfi®

European Commission Formycon Fresenius Kabi FYB202 Ustekinumab
BRIEF

published on 09/27/2024 at 09:05, 1 year 6 months ago

La Commission européenne approuve le biosimilaire FYB202/Otulfi® de Formycon et Fresenius Kabi

Formycon Fresenius Kabi FYB202 Ustekinumab Commission Européenne

Accesswire

Published on 03/28/2026 at 01:00, 23 hours 37 minutes ago

Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 03/28/2026 at 00:55, 23 hours 42 minutes ago

Notification of Relevant Change to Significant Shareholder
Published on 03/28/2026 at 00:50, 23 hours 47 minutes ago

"Rise" Selected as NASA Artemis II Moon Mascot
Published on 03/27/2026 at 22:45, 1 day 1 hour ago

Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 03/27/2026 at 22:30, 1 day 2 hours ago

Usha Resources Completes Extended Induced Polarization Survey at the Southern Arm Property

View all ACCESSWIRE

EQS Group

Published on 03/28/2026 at 10:05, 14 hours 31 minutes ago

Hisense Advances a Quiet Green Revolution in Home Entertainment
Published on 03/28/2026 at 08:56, 15 hours 40 minutes ago

Turkiye Garanti Bankasi A.S.: Sale of Garanti Bank S.A. and our public disclosure dated 10.03.2026
Published on 03/28/2026 at 01:42, 22 hours 54 minutes ago

EQS-Adhoc: Raiffeisen Bank International AG: Agreement on the acquisition of Garanti BBVA Group Romania
Published on 03/27/2026 at 21:58, 1 day 2 hours ago

Kaufman & Broad SA: Availability of the Universal Registration Document 2025
Published on 03/27/2026 at 21:58, 1 day 2 hours ago

Kaufman & Broad SA: Mise à disposition du Document d'Enregistrement Universel 2025

Les Echos

Published on 03/28/2026 at 07:00, 17 hours 37 minutes ago

Groupe DLSI - Résultat 2025
Published on 03/27/2026 at 19:06, 1 day 5 hours ago

Mersen : Déclaration des transactions sur actions propres
Published on 03/27/2026 at 19:06, 1 day 5 hours ago

Mersen: Disclosure of trading own shares
Published on 03/27/2026 at 18:52, 1 day 5 hours ago

Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:52, 1 day 5 hours ago

Crédit Agricole CIB annonce la publication de son Document d’enregistrement universel 2025

View all LES ECHOS COMFI WIRE